Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Casirivimab/i..
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Sotrovimab
Vitamin A
Vitamin C
Vitamin D
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Sleep  COVID-19 treatment studies for Sleep  C19 studies: Sleep  Sleep   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Lactoferrin (meta)
Aspirin (meta) Melatonin (meta)
Bamlaniv../e.. (meta) Metformin (meta)
Bebtelovimab (meta) Molnupiravir (meta)
Bromhexine (meta) N-acetylcys.. (meta)
Budesonide (meta) Nigella Sativa (meta)
Cannabidiol (meta) Nitazoxanide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)

Other Treatments Global Adoption
 
Sleep COVID-19 studies. Studies analyze sleep quality before infection. Recent:
Paul
Marcus
Holt
Kim
Mohsin
Li
Huang.
Submit updates/corrections.
May 20
Early, Late, PrEP, PEP Covid Analysis (Preprint) (meta analysis)
meta-analysis
Sleep for COVID-19: real-time meta analysis of 7 studies
Details   • Statistically significant improvements are seen for mortality, hospitalization, recovery, and cases. 7 studies from 7 independent teams in 4 different countries show statistically significant improvements in isolation (6 for the most se..
Apr 13
PrEPPEP Paul et al., medRxiv, doi:10.1101/2022.04.12.22273792 (Preprint)
no recov., ↓67.3%, p<0.0001
Health behaviours the month prior to COVID-19 infection and the development of self-reported long COVID and specific long COVID symptoms: A longitudinal analysis of 1,811 UK adults
Details   Retrospective 1,811 COVID-19 patients in the UK, showing lower risk of self-reported long COVID with good sleep quality in the month before infection.
Mar 22
PrEPPEP Kim et al., BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000228
m/s case, ↓17.0%, p=0.03
COVID-19 illness in relation to sleep and burnout
Details   Retrospective 2,884 high-risk healthcare workers in France, Germany, Italy, Spain, UK, and the USA, showing shorter sleep duration associated with increased risk of COVID-19 cases and severity.
Nov 30
2021
PrEPPEP Huang et al., Nature and Science of Sleep, doi:10.2147/NSS.S263488
severe case, ↓80.9%, p=0.02
Reduced Sleep in the Week Prior to Diagnosis of COVID-19 is Associated with the Severity of COVID-19
Details   Retrospective 164 COVID-19 patients and 188 controls in China, showing the risk of severe cases associated with lack of sleep.
Sep 30
2021
PrEPPEP Mohsin et al., Infection and Drug Resistance, doi:10.2147/IDR.S331470
severe case, ↓37.9%, p<0.0001
Lifestyle and Comorbidity-Related Risk Factors of Severe and Critical COVID-19 Infection: A Comparative Study Among Survived COVID-19 Patients in Bangladesh
Details   Retrospective 1,500 COVID+ patients in Bangladesh, showing lower risk of severe cases with good sleep.
Jun 18
2021
PrEPPEP Li et al., Sleep, doi:10.1093/sleep/zsab138
death, ↓43.2%, p=0.02
Poor sleep behavior burden and risk of COVID-19 mortality and hospitalization
Details   UK Biobank retrospective, 46,535 participants with sleep behavior assessed between 2006 and 2010, showing higher risk of hospitalization and mortality with poor sleep.
Jun 17
2021
PrEPPEP Marcus et al., PLOS ONE, doi:10.1371/journal.pone.0253120
symp. case, ↓16.0%, p=0.0007
Predictors of incident viral symptoms ascertained in the era of COVID-19
Details   Prospective survey based study with 14,335 participants, showing risk of viral symptoms associated with shorter sleep duration.
Mar 30
2021
PrEPPEP Holt et al., Thorax, doi:10.1136/thoraxjnl-2021-217487
cases, ↓12.3%, p=0.50
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)
Details   Prospective survey-based study with 15,227 people in the UK, showing reduced risk of COVID-19 cases with 8 hours sleep, with statistical significance when compared with ≥9 hours. NCT04330599. COVIDENCE UK.
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit